Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Craniofacial Abnormalities | 3 | 2021 | 315 | 1.100 |
Why?
|
Cerebral Palsy | 3 | 2024 | 472 | 0.880 |
Why?
|
DNA Polymerase III | 1 | 2022 | 51 | 0.800 |
Why?
|
Iron-Sulfur Proteins | 1 | 2022 | 83 | 0.790 |
Why?
|
Lipodystrophy | 1 | 2022 | 148 | 0.740 |
Why?
|
Language Development Disorders | 1 | 2021 | 192 | 0.670 |
Why?
|
Databases, Genetic | 1 | 2023 | 1737 | 0.550 |
Why?
|
Dwarfism | 1 | 2016 | 137 | 0.510 |
Why?
|
Limb Deformities, Congenital | 1 | 2016 | 136 | 0.510 |
Why?
|
Heterozygote | 1 | 2021 | 2797 | 0.460 |
Why?
|
Urogenital Abnormalities | 1 | 2016 | 256 | 0.440 |
Why?
|
RNA-Binding Proteins | 1 | 2021 | 1894 | 0.400 |
Why?
|
Phenotype | 11 | 2024 | 16534 | 0.390 |
Why?
|
Syndrome | 6 | 2022 | 3262 | 0.350 |
Why?
|
Genetic Variation | 1 | 2023 | 6548 | 0.310 |
Why?
|
Tuberous Sclerosis | 2 | 2014 | 1030 | 0.280 |
Why?
|
Genetic Predisposition to Disease | 2 | 2022 | 17768 | 0.210 |
Why?
|
Developmental Disabilities | 4 | 2021 | 1504 | 0.210 |
Why?
|
Child, Preschool | 14 | 2024 | 42062 | 0.210 |
Why?
|
Genetic Testing | 3 | 2024 | 3530 | 0.200 |
Why?
|
Facies | 3 | 2021 | 222 | 0.200 |
Why?
|
Pedigree | 5 | 2024 | 4578 | 0.200 |
Why?
|
Spastic Paraplegia, Hereditary | 1 | 2024 | 168 | 0.200 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7378 | 0.180 |
Why?
|
Population Surveillance | 1 | 2011 | 2606 | 0.180 |
Why?
|
Chromosome Disorders | 1 | 2023 | 499 | 0.180 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2024 | 677 | 0.170 |
Why?
|
Pathology, Molecular | 1 | 2022 | 328 | 0.170 |
Why?
|
Mutation | 5 | 2024 | 29915 | 0.170 |
Why?
|
Haploinsufficiency | 1 | 2021 | 327 | 0.160 |
Why?
|
Ephrin-B1 | 1 | 2017 | 24 | 0.150 |
Why?
|
Mediator Complex | 1 | 2017 | 106 | 0.140 |
Why?
|
Child | 13 | 2024 | 79818 | 0.140 |
Why?
|
Cognition Disorders | 1 | 2011 | 3975 | 0.140 |
Why?
|
Mutation, Missense | 2 | 2022 | 2564 | 0.130 |
Why?
|
Persistent Fetal Circulation Syndrome | 1 | 2016 | 80 | 0.130 |
Why?
|
Pierre Robin Syndrome | 1 | 2017 | 117 | 0.130 |
Why?
|
Alleles | 4 | 2024 | 6895 | 0.120 |
Why?
|
Genomic Imprinting | 1 | 2016 | 330 | 0.120 |
Why?
|
Point Mutation | 1 | 2019 | 1593 | 0.110 |
Why?
|
Craniosynostoses | 1 | 2017 | 412 | 0.110 |
Why?
|
Pulmonary Alveoli | 1 | 2016 | 651 | 0.110 |
Why?
|
Orofaciodigital Syndromes | 1 | 2012 | 21 | 0.110 |
Why?
|
GTPase-Activating Proteins | 1 | 2016 | 474 | 0.110 |
Why?
|
Nerve Tissue Proteins | 2 | 2023 | 4406 | 0.100 |
Why?
|
Australia | 2 | 2017 | 1276 | 0.100 |
Why?
|
Infant | 7 | 2024 | 36055 | 0.100 |
Why?
|
Adolescent | 9 | 2024 | 87892 | 0.100 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 1136 | 0.100 |
Why?
|
Caregivers | 1 | 2024 | 2225 | 0.100 |
Why?
|
Histones | 1 | 2022 | 2577 | 0.100 |
Why?
|
Zebrafish | 1 | 2022 | 2993 | 0.090 |
Why?
|
China | 1 | 2016 | 2333 | 0.090 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2011 | 92 | 0.090 |
Why?
|
Pulmonary Veins | 1 | 2016 | 745 | 0.090 |
Why?
|
Humans | 25 | 2024 | 758406 | 0.080 |
Why?
|
Astrocytoma | 1 | 2014 | 775 | 0.080 |
Why?
|
Kyphosis | 1 | 2011 | 237 | 0.080 |
Why?
|
Male | 16 | 2024 | 358747 | 0.080 |
Why?
|
Genotype | 3 | 2024 | 12945 | 0.080 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2024 | 3701 | 0.080 |
Why?
|
Female | 17 | 2024 | 390323 | 0.070 |
Why?
|
Brain Diseases | 1 | 2016 | 1541 | 0.070 |
Why?
|
Sirolimus | 1 | 2014 | 1533 | 0.070 |
Why?
|
Cohort Studies | 3 | 2022 | 41256 | 0.070 |
Why?
|
Transcription Factors | 3 | 2024 | 12094 | 0.060 |
Why?
|
Gene Deletion | 1 | 2012 | 2666 | 0.060 |
Why?
|
Scoliosis | 1 | 2011 | 734 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2021 | 7843 | 0.060 |
Why?
|
Anticonvulsants | 1 | 2014 | 1881 | 0.060 |
Why?
|
Genetic Association Studies | 3 | 2021 | 2717 | 0.060 |
Why?
|
Abnormalities, Multiple | 1 | 2011 | 1414 | 0.060 |
Why?
|
Genome, Human | 1 | 2016 | 4416 | 0.050 |
Why?
|
Molecular Sequence Data | 2 | 2016 | 17617 | 0.050 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2023 | 346 | 0.050 |
Why?
|
DNA Mutational Analysis | 3 | 2017 | 4106 | 0.050 |
Why?
|
DEAD-box RNA Helicases | 1 | 2024 | 383 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2011 | 2800 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4284 | 0.040 |
Why?
|
Brain | 3 | 2023 | 26947 | 0.040 |
Why?
|
Signal Transduction | 2 | 2021 | 23342 | 0.040 |
Why?
|
Young Adult | 2 | 2021 | 58808 | 0.040 |
Why?
|
Codon, Nonsense | 1 | 2021 | 281 | 0.040 |
Why?
|
Microarray Analysis | 1 | 2022 | 746 | 0.040 |
Why?
|
Frameshift Mutation | 1 | 2021 | 388 | 0.040 |
Why?
|
Chromosome Deletion | 1 | 2023 | 1387 | 0.040 |
Why?
|
Epilepsy | 1 | 2014 | 3269 | 0.040 |
Why?
|
Fibroblast Growth Factor 10 | 1 | 2017 | 31 | 0.040 |
Why?
|
Proteins | 1 | 2012 | 6026 | 0.040 |
Why?
|
Cranial Sutures | 1 | 2017 | 92 | 0.040 |
Why?
|
Age of Onset | 1 | 2024 | 3298 | 0.040 |
Why?
|
New Zealand | 1 | 2017 | 352 | 0.040 |
Why?
|
Adult | 5 | 2021 | 219935 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2017 | 256 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2016 | 2057 | 0.030 |
Why?
|
Genes, Lethal | 1 | 2016 | 225 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2016 | 473 | 0.030 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2016 | 342 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3615 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2022 | 2012 | 0.030 |
Why?
|
DNA-Binding Proteins | 2 | 2024 | 9574 | 0.030 |
Why?
|
Societies, Medical | 1 | 2024 | 3891 | 0.030 |
Why?
|
Self Report | 1 | 2024 | 3714 | 0.030 |
Why?
|
Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2011 | 7 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2016 | 1492 | 0.020 |
Why?
|
Foot Deformities, Congenital | 1 | 2011 | 59 | 0.020 |
Why?
|
Corpus Callosum | 1 | 2016 | 749 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13591 | 0.020 |
Why?
|
X Chromosome Inactivation | 1 | 2012 | 226 | 0.020 |
Why?
|
Hand Deformities, Congenital | 1 | 2011 | 174 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2938 | 0.020 |
Why?
|
Muscle Hypotonia | 1 | 2011 | 160 | 0.020 |
Why?
|
Introns | 1 | 2012 | 978 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1611 | 0.020 |
Why?
|
Protein Conformation | 1 | 2016 | 3966 | 0.020 |
Why?
|
DNA | 1 | 2022 | 7199 | 0.020 |
Why?
|
Family Health | 1 | 2012 | 1257 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2012 | 1090 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2017 | 2980 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4711 | 0.020 |
Why?
|
Exons | 1 | 2012 | 2387 | 0.020 |
Why?
|
Cognition | 1 | 2024 | 6953 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 80168 | 0.020 |
Why?
|
Face | 1 | 2011 | 1017 | 0.020 |
Why?
|
Amino Acids | 1 | 2011 | 1713 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2016 | 13447 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2017 | 36284 | 0.010 |
Why?
|
Risk Factors | 1 | 2011 | 73809 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5786 | 0.010 |
Why?
|
Base Sequence | 1 | 2012 | 12436 | 0.010 |
Why?
|
Prospective Studies | 2 | 2017 | 54137 | 0.010 |
Why?
|
Fibroblasts | 1 | 2011 | 4087 | 0.010 |
Why?
|
Middle Aged | 2 | 2011 | 219568 | 0.010 |
Why?
|
Biopsy | 1 | 2011 | 6768 | 0.010 |
Why?
|
Animals | 2 | 2022 | 167768 | 0.010 |
Why?
|
Skin | 1 | 2011 | 4464 | 0.010 |
Why?
|
United States | 1 | 2024 | 72136 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2016 | 26183 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 18940 | 0.010 |
Why?
|
Mice | 1 | 2019 | 81101 | 0.010 |
Why?
|
Aged | 1 | 2021 | 168218 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2014 | 64378 | 0.000 |
Why?
|
Concepts
(142)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(39)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_